机构:[1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan, China云南省第一人民医院[2]Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China外科科室骨科昆明医科大学附属第一医院
Objective: Osteosarcoma is a common malignancy with high rate of metastasis. miR-10b has been reported to be expressed in many types of tumors abnormally and be associated with cancer carcinogenesis and progression. But the function of miR-10b in osteosarcoma is still unknown. So this study was aimed to investigate the role of miR-10b in osteosarcoma development. Methods: miR-10b expression in osteosarcoma tissues and osteosarcoma cells were detected using real time PCR. The effects of miR-10b on osteosarcoma cells proliferation, apoptosis, migration and invasion were detected using CCK-8 assay, flow cytometry, wound-healing assay and transwell assay, respectively. The relationship between miR-10b and KLF4 was evaluated using dual-luciferase assay, correlation analysis. Results: miR-10b was highly expressed in osteosarcoma tissues and osteosarcoma cells. Furthermore, inhibition of miR-10b in osteosarcoma cells depressed the cells proliferation, migration and invasion but promoted cells apoptosis. In addition, KLF4 was down-regulated by miR-10b and miR-10b expression was negatively related to KLF4 expression in osteosarcoma tissue, miR-10b participated in the process of osteosarcoma cells invasion by regulating KLF4 expression. Conclusion: miR-10b is overexpressed in osteosarcoma and KLF4 is the direct target gene of miR-10b. Furthermore, miR-10b promotes osteosarcoma cells progression by downregulating KLF4 expression. These results suggest that miR-10b functions as an oncomiR and play an important role in osteosarcoma cellular processes at least partially through regulating KLF4; miR-10b may be a therapeutic target for osteosarcoma treatment. (C) 2016 Elsevier Masson SAS. All rights reserved.
基金:
National Science Foundation of ChinaNational Natural Science Foundation of China [nsfc81660215, nsfc81260286]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|3 区药学4 区医学:研究与实验
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2016]版:
Q2MEDICINE, RESEARCH & EXPERIMENTALQ2PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Department of Rheumatology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan, China
共同第一作者:
通讯作者:
通讯机构:[*1]Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming 650032, Yunnan Province, China.
推荐引用方式(GB/T 7714):
Wang Jing,Wang Bing,Chen Ling-Qiang,et al.miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells[J].BIOMEDICINE & PHARMACOTHERAPY.2016,84:947-953.doi:10.1016/j.biopha.2016.09.108.
APA:
Wang, Jing,Wang, Bing,Chen, Ling-Qiang,Yang, Jin,Gong, Zhi-Qiang...&Du, Kai-Li.(2016).miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells.BIOMEDICINE & PHARMACOTHERAPY,84,
MLA:
Wang, Jing,et al."miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells".BIOMEDICINE & PHARMACOTHERAPY 84.(2016):947-953